Normal Repetitive Pregnancies and Tumor Regression Induced by Low-Dose Bromocriptine in a Patient with Macroprolactinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최혜정 | - |
dc.contributor.author | 박진용 | - |
dc.contributor.author | 김희영 | - |
dc.contributor.author | 서지아 | - |
dc.contributor.author | 김신곤 | - |
dc.contributor.author | 김난희 | - |
dc.contributor.author | 최경묵 | - |
dc.contributor.author | 백세현 | - |
dc.contributor.author | 최동섭 | - |
dc.contributor.author | 최우석 | - |
dc.contributor.author | 송종규 | - |
dc.date.available | 2020-11-03T08:49:22Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 2093-596X | - |
dc.identifier.issn | 2093-5978 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/16348 | - |
dc.format.extent | 5 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한내분비학회 | - |
dc.title | Normal Repetitive Pregnancies and Tumor Regression Induced by Low-Dose Bromocriptine in a Patient with Macroprolactinoma | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.bibliographicCitation | Endocrinology and Metabolism, v.24, no.1, pp 42 - 46 | - |
dc.citation.title | Endocrinology and Metabolism | - |
dc.citation.volume | 24 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 42 | - |
dc.citation.endPage | 46 | - |
dc.identifier.kciid | ART001332254 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Bromocriptine | - |
dc.subject.keywordAuthor | macroprolactinoma | - |
dc.subject.keywordAuthor | pregnancy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841) 82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.